Researchers have developed an algorithm for differentiating between healthy women and those with ovarian cancer, as well as differentiating BRCA1 mutated-disease from wild-type disease. READ MORE

News

The length of time between the end of adjuvant platinum-based therapy and the recurrence of cancer is a strong predictor of survival in older women with recurrent ovarian cancer.

READ MORE

A recent survey asked patients with primary and recurrent ovarian cancer to consider their reasons for choosing maintenance therapy following surgery and chemotherapy.

READ MORE